Published Guidance, NICE advice and quality standards
Showing 31 to 36 of 36
Title | Reference number | Published | Last updated |
---|---|---|---|
Elotuzumab for previously treated multiple myeloma (terminated appraisal) | TA434 | ||
Pomalidomide for multiple myeloma previously treated with lenalidomide and bortezomib | TA427 | ||
Panobinostat for treating multiple myeloma after at least 2 previous treatments | TA380 | ||
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantation | TA311 | ||
Bortezomib and thalidomide for the first‑line treatment of multiple myeloma | TA228 | ||
Bortezomib monotherapy for relapsed multiple myeloma | TA129 |